This study reported dosing patterns for aripiprazole augmentation for major depressive disorder in a naturalistic treatment setting. The records of a total of 276 patients were reviewed. The mean ...

Aripiprazole 2mg, 5mg, 10mg, 15mg, 20mg, 30mg; tabs with ingestible event marker (IEM) sensor. Ability to improve patient compliance or modify dosage has not been established. Use for real-time drug ...

Aripiprazole is a generic drug prescribed for certain conditions, including schizophrenia, in adults and some children. The medication is available as the brand-name drugs Abilify, Abilify Asimtufii, ...

Aripiprazole (Abilify, Bristol-Myers Squibb and Otsuka Pharmaceuticals) has a UK marketing authorisation for the treatment of schizophrenia in people aged 15 years and older. The initial marketing ...

Abilify is available in several different brand-name versions: Abilify comes as a tablet that you swallow. Abilify MyCite comes as a tablet with a sensor that you swallow.* Abilify Maintena comes as ...

PRINCETON, NJ and TOKYO, JAPAN, November 20, 2007 – Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) ...

Aripiprazole 10mg, 15mg; vanilla flavor; contains phenylalanine. The mechanism of action of aripiprazole in the treatment of schizophrenia, bipolar I disorder, or adjunctive treatment of major ...

November 24, 2009 — The US Food and Drug Administration (FDA) has approved an expanded indication for the oral formulation of aripiprazole (Abilify tablets, orally disintegrating tablets, and oral ...